The Food and Drug Administration said it believes rapid antigen tests may be more likely to produce false negatives against omicron than other variants of COVID-19.
The FDA authorizes the use of antigen tests to identify COVID-19 but recommends individuals with symptoms take a molecular test.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.